rbor" for certain forward-
looking statements. Statements relating to future results of operations in
this document reflect the current views of management. However, various
risks, uncertainties and contingencies could cause actual results or
performance to differ materially from those expressed in, or implied by,
these statements, including the Company's ability to enter into and derive
benefits from managed care contracts, the demand for the Company's orthotic
and prosthetic services and products and the other factors identified in
the Company's periodic reports on Form 10-K and Form 10-Q filed with the
Securities and Exchange Commission under the Securities Exchange Act of
1934. The Company disclaims any intent or obligation to update publicly
these forward-looking statements, whether as a result of new information,
future events or otherwise.
Hanger Orthopedic Group, Inc.
(Dollars in thousands, except share and per share amounts)
(unaudited)
Three Months Ended Year Ended
Income Statement: December 31, December 31,
2007 2006 2007 2006
Net sales $170,790 $153,918 $637,350 $598,766
Cost of goods sold
(exclusive of depreciation
and amortization) 76,496 78,275 307,952 300,065
Selling, general and
administrative 70,797 53,646 245,542 221,592
Depreciation and
amortization 4,307 3,593 15,876 14,670
Income from operations 19,190 18,404 67,980 62,439
Interest expense, net 9,204 9,377 36,987 38,643
Extinguishment of debt - - - 16,953
Income before taxes 9,986 9,027
'/>"/>
SOURCE Hanger Orthopedic Group, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1.
Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 20072.
Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)3.
Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue4.
Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call5.
Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance6.
Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year7.
QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes8.
QED International Announces Changes to the HealthShares(TM) Orthopedic Repair Index9.
Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com10.
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO11.
Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide